LPL Financial
HUMA icon

LPL Financial’s Humacyte HUMA Stock Holding History

LPL Financial’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$800K Buy
1,025,535
+161,072
+19% +$149K ﹤0.01% 4613
2026
Q1 		$524K Buy
864,463
+26,802
+3% +$27.9K ﹤0.01% 4715
2025
Q4 		$805K Buy
837,661
+46,904
+6% +$66.4K ﹤0.01% 4289
2025
Q3 		$1.38M Buy
790,757
+65,957
+9% +$129K ﹤0.01% 3679
2025
Q2 		$1.51M Buy
724,800
+90,818
+14% +$174K ﹤0.01% 3381
2025
Q1 		$1.08M Buy
633,982
+103,990
+20% +$390K ﹤0.01% 3493
2024
Q4 		$2.68M Buy
529,992
+18,000
+4% +$89.1K ﹤0.01% 2600
2024
Q3 		$2.79M Buy
511,992
+48,740
+11% +$321K ﹤0.01% 2429
2024
Q2 		$2.22M Buy
463,252
+43,157
+10% +$225K ﹤0.01% 2507
2024
Q1 		$1.31M Buy
420,095
+52,550
+14% +$177K ﹤0.01% 2941
2023
Q4 		$1.04M Buy
367,545
+26,063
+8% +$66.9K ﹤0.01% 3010
2023
Q3 		$1M Buy
341,482
+25,342
+8% +$83.8K ﹤0.01% 2888
2023
Q2 		$904K Buy
316,140
+37,300
+13% +$134K ﹤0.01% 2919
2023
Q1 		$862K Sell
278,840
-5,700
-2% -$16.2K ﹤0.01% 2861
2022
Q4 		$600K Sell
284,540
-28,500
-9% -$86.5K ﹤0.01% 3085
2022
Q3 		$1.02M Buy
313,040
+15,500
+5% +$59.4K ﹤0.01% 2527
2022
Q2 		$955K Buy
+297,540
New +$1.65M ﹤0.01% 2608
2022
Q1 		– Sell
-238,865
Closed -$1.73M – 4290
2021
Q4 		$1.73M Buy
238,865
+124,250
+108% +$1.23M ﹤0.01% 2198
2021
Q3 		$1.33M Buy
+114,615
New +$1.31M ﹤0.01% 2386

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

LPL Financial's HUMA Position: Q2 2026 in Review

LPL Financial increased its Humacyte (HUMA) stake by 19% in Q2 2026, buying an estimated $149K and bringing the position to 1,025,535 shares worth $800K. The position accounts for ﹤0.01% of the portfolio, ranked #4613.

LPL Financial first reported a position in HUMA in Q3 2021 and has held it in 19 quarters since. The position peaked at $2.79M in Q3 2024. 163 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • LPL Financial held 1,025,535 shares of Humacyte worth $800K as of Q2 2026.
  • LPL Financial bought 161,072 Humacyte shares in Q2 2026, an estimated $149K.
  • Humacyte made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #4613 holding.
  • LPL Financial first reported a position in Humacyte in Q3 2021 and has held it in 19 quarters since.
  • LPL Financial's Humacyte position peaked at $2.79M in Q3 2024.
  • 163 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.